Published in J Biol Chem on January 15, 1986
Platelet-activating factor: receptors and signal transduction. Biochem J (1993) 2.12
Inactivation of platelet-activating factor by a putative acetylhydrolase from the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunology (1992) 0.92
Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. J Cell Biol (1988) 0.89
Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion. Gut (1996) 0.86
Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. Br J Pharmacol (1988) 0.85
The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers. Biochem J (1994) 0.78
Solubilization of a functionally active platelet-activating factor receptor from rabbit platelets. Biochem J (1991) 0.77
Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate. Biochem J (1992) 0.77
Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus. Br J Pharmacol (1991) 0.75
A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (1996) 5.45
Selective and reversible inhibition of initiation of protein synthesis in mammalian cells. J Mol Biol (1974) 3.41
Nuclear targeting signal recognition: a key control point in nuclear transport? Bioessays (2000) 3.17
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem (2000) 1.84
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Differential subcellular localization of hepatitis C virus core gene products. Virology (1995) 1.73
Identification of receptors for neuromedin U and its role in feeding. Nature (2000) 1.60
Homotypic interaction and multimerization of hepatitis C virus core protein. Virology (1996) 1.51
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry (1983) 1.49
Receptor for motilin identified in the human gastrointestinal system. Science (1999) 1.39
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A (1995) 1.34
Inhibition of initiation of protein synthesis in mammalian tissue culture cells by L-1-tosylamido-2-phenylethyl chloromethyl ketone. J Biol Chem (1975) 1.33
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem (1998) 1.32
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun (1999) 1.32
Calcitonin receptor antibodies in the identification of osteoclasts. Bone (1999) 1.29
Purple membrane vesicles: morphology and proton translocation. J Membr Biol (1977) 1.29
Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci U S A (2001) 1.24
Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema. Eur J Pharmacol (1986) 1.24
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proc Natl Acad Sci U S A (1985) 1.24
PC8 [corrected], a new member of the convertase family. Biochem J (1996) 1.16
Characterization of a leukotriene D4 receptor in guinea pig lung. Proc Natl Acad Sci U S A (1983) 1.14
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. J Biol Chem (1985) 1.14
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Lab Invest (1985) 1.14
A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women. BJOG (2002) 1.11
Prostaglandin production by methylcholanthrene-transformed mouse BALB/3T3. Requirement for protein synthesis. J Biol Chem (1977) 1.10
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. Biochem Biophys Res Commun (1988) 1.07
Transient photovoltages in purple membrane multilayers. Charge displacement in bacteriorhodopsin and its photointermediates. Biochim Biophys Acta (1978) 1.06
Leukotriene C4 binding to rat lung membranes. J Biol Chem (1983) 1.06
A nonpeptidyl growth hormone secretagogue. Science (1993) 1.04
Nuclear import of Creb and AP-1 transcription factors requires importin-beta 1 and Ran but is independent of importin-alpha. Biochemistry (2001) 1.02
Review of effects of water pollution on the breeding success of waterbirds, with particular reference to ardeids in Hong Kong. Ecotoxicology (2001) 1.02
Specific binding sites for platelet activating factor in human lung tissues. Biochem Biophys Res Commun (1985) 1.01
Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine. Br J Radiol (2010) 1.01
Ureaplasma urealyticum in patients with acute symptoms of urinary tract infection. J Urol (1982) 0.98
Multiple nuclear ribonucleic acid polymerases during development of Dictyostelium discoideum. J Biol Chem (1973) 0.97
Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res (1996) 0.96
A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro. J Lipid Res (1999) 0.96
Discovery, production and purification of the Na+, K+ activated ATPase inhibitor, L-681,110 from the fermentation broth of Streptomyces sp. MA-5038. J Antibiot (Tokyo) (1984) 0.96
Growth hormone secretagogue receptor family members and ligands. Endocrine (2001) 0.95
Proton transport by bacteriorhodopsin in planar membranes assembled from air-water interface films. J Gen Physiol (1980) 0.95
Studies on the mechanism of action of avermectin B1a: stimulation of release of gamma-aminobutyric acid from brain synaptosomes. J Neurochem (1980) 0.94
Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway. Biochem Biophys Res Commun (2001) 0.94
Proton transport by bacteriorhodopsin through an interface film. J Membr Biol (1977) 0.92
Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA. Virology (1998) 0.91
Species difference in the specific receptors of platelet activating factor. Biochem Pharmacol (1986) 0.91
The specificity of high affinity binding of avermectin B1a to mammalian brain. Neuropharmacology (1980) 0.90
Rac GTPase activity is essential for EGF-induced mitogenesis. Mol Cells (1998) 0.88
Avermectin B1a modulation of gamma-aminobutyric acid receptors in rat brain membranes. J Neurochem (1982) 0.87
Adenomatous hyperplastic polyp of the gall bladder associated with cholelithiasis in a child. Pediatr Surg Int (2003) 0.86
Actions of avermectin B1a on GABA nerves. Prog Clin Biol Res (1982) 0.86
Prolongation of parturition in the pregnant rat following treatment with a platelet activating factor receptor antagonist. Biol Reprod (1991) 0.86
Lung tissue receptors for sulfidopeptide leukotrienes. J Allergy Clin Immunol (1984) 0.86
Biosynthesis of prostaglandins in rabbit renal cortex. Res Commun Chem Pathol Pharmacol (1976) 0.85
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2. Virus Res (2001) 0.85
Prostaglandin production by methylcholanthrene-transformed mouse BALB/3T3: inhibition by cytochalasin B. Prostaglandins (1976) 0.85
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. J Pharmacol Exp Ther (1988) 0.85
Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes. J Med Chem (1981) 0.84
Structural and spectroscopic characteristics of bacteriorhodopsin in air-water interface films. J Membr Biol (1977) 0.84
Predictors of functional outcome after emergency carotid artery stenting and intra-arterial thrombolysis for treatment of acute stroke associated with obstruction of the proximal internal carotid artery and tandem downstream occlusion. AJNR Am J Neuroradiol (2012) 0.84
Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors. Mol Pharmacol (1989) 0.83
Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma. Clin Radiol (2010) 0.83
SUMOylation of nonstructural 5A protein regulates hepatitis C virus replication. J Viral Hepat (2014) 0.83
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor. J Biol Chem (1986) 0.82
Enzymes of amino acid metabolism in Dictyostelium discolideum. I. Tyrosine transaminase. J Biol Chem (1971) 0.81
Replacement of an anabolic threonine deaminase by a catabolic threonine deaminase during development of Dictyostelium discoideum. J Biol Chem (1973) 0.81
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxel. J Pharm Biomed Anal (2007) 0.80
Distribution of prostaglandin E 9-KETOREDUCTASE AND TYPES I and II 15-hydroxyprostaglandin dehydrogenase in swine kidney medulla and cortex. Biochemistry (1975) 0.80
A comparative study of avermectin B1a and other modulators of the gamma-aminobutyric acid receptor . chloride ion channel complex. J Neurosci (1982) 0.79
Determination of microcystins in cyanobacterial blooms by solid-phase microextraction-high-performance liquid chromatography. Environ Toxicol Chem (2001) 0.79
Recent development of platelet-activating factor antagonists. Adv Prostaglandin Thromboxane Leukot Res (1989) 0.79
Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages. Proc Natl Acad Sci U S A (1981) 0.79
Characterization and translational regulation of the arginine decarboxylase gene in carnation (Dianthus caryophyllus L.). Plant J (2000) 0.78
Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication. J Viral Hepat (2008) 0.78
Stereospecificity of enzymatic reduction of prostaglandin E2 to F2alpha. Prostaglandins (1975) 0.78
Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagation. J Viral Hepat (2011) 0.78
Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists. J Med Chem (1986) 0.77
L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors. Lipids (1991) 0.77
[Neolignans from Piper polysyphorum C.DC]. Yao Xue Xue Bao (1991) 0.77
Prostaglandin synthetase systems of rabbit tissues and their inhibition by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther (1976) 0.77
Functional domains of hepatitis delta antigen. Prog Clin Biol Res (1993) 0.77
Effects of radiation therapy on vascular responsiveness. J Cardiovasc Pharmacol (2001) 0.76
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. Pharmacol Res (2001) 0.76
The effects of endurance exercise on dystrophic mdx mice. II. Contractile properties of skinned muscle fibres. Proc Biol Sci (1993) 0.76
Solubilization and characterization of a growth hormone secretagogue receptor from porcine anterior pituitary membranes. Biochem Biophys Res Commun (1996) 0.75
Endovascular management in patients with acute basilar artery obstruction: low-dose intra-arterial urokinase and mechanical clot disruption. Interv Neuroradiol (2011) 0.75
Balloon-expandable stent placement in patients with immediate reocclusion after initial successful thrombolysis of acute middle cerebral arterial obstruction. Interv Neuroradiol (2012) 0.75
Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues. Bioorg Med Chem Lett (2000) 0.75
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor. J Lipid Mediat (1993) 0.75
Determination of polychlorinated biphenyls in human blood serum by SPME. Chemosphere (1999) 0.75
Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor. J Med Chem (1996) 0.75
[Neolignans from Piper hancei Maxim]. Yao Xue Xue Bao (1986) 0.75